Christopher Aadland

Articles

Department of Psychiatry head steps down

Dr. Charles Schulz has stepped down as head of the University of MinnesotaâÄôs Department of Psychiatry. Schulz steps down amid scrutiny of the UniversityâÄôs human research programs, housed within the Psychiatry Department. Two recently released reports found flaws and ethical concerns in the schoolâÄôs human research programs. One of the external reports released earlier this year, managed by the Association for the Accreditation of Human Research Protection Programs, noted a culture of fear and retaliation within the psychiatry department.


Research in limbo after suspension

University of Minnesota researchers are voicing concerns over the psychiatric departmentâÄôs long-term future amid discussions between school and state officials on the institutionâÄôs research practices. Last month, University President Eric Kaler halted enrollment in 17 University psychiatric drug trials âÄî which include studies of schizophrenia, depression in adolescents and autism âÄî after two external reports found flaws and ethical concerns in the schoolâÄôs human research programs.


Kaler talks fees, Dan Markingson case

One day after University of Minnesota President Eric Kaler gave his fourth State of the University address, he sat down with the Minnesota Daily for AprilâÄôs edition of KickinâÄô It with Kaler. Kaler discussed a recent report that cited ethical concerns in the UniversityâÄôs human research programs, the qualities heâÄôd like to see in the schoolâÄôs new police chief and the upcoming Rolling Stones concert at TCF Bank Stadium.


Board acts on Kaler’s request

The University of Minnesota Board of Regents vowed to make the school’s human research programs “beyond reproach” after two recent reports highlighted ethical concerns and faulted the institution for inadequately protecting its human research subjects. Regents responded to the reports and approved resulting steps the University will take at a meeting Friday. Among other changes, the board approved suspending psychiatric drug trials and creating a Community Oversight Board to ensure the school’s human research subjects are being properly protected.


Board approves psychiatric drug trial suspension

The University of Minnesota Board of Regents unanimously approved plans Friday to make the school’s human subjects research program “beyond reproach” after two external reports highlighted areas of concern where the University should improve their protection practices.


Kaler talks budget, UMore

Earlier this month, when snow was melting and temperatures were warming up, the Minnesota Daily sat down with University of Minnesota President Eric Kaler for its monthly Kickin’ it with Kaler interview. Kaler discussed changes to the University’s crime alerts, administrative spending, UMore Park’s new direction and Duluth campus’s $6 million budget deficit.  


After scathing report, U halts drug trials

More than a decade of scrutiny over the University of Minnesota’s handling of a drug trial participant’s death and the institution’s research ethics has prompted a swath of proposed changes.